香雪XPH品牌怎么样 申请店铺

我要投票 香雪XPH在医疗器械行业中的票数:99 更新时间:2025-02-24
香雪XPH是哪个国家的品牌?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!通过在本页面挂载香雪XPH品牌的产品链接和联系邮箱,可以提高香雪XPH产品曝光!跨境电商爆单神器,目前只要100元/年哦~

香雪XPH怎么样

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://brand.waitui.com/5a03ebbad.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

18分钟前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

18分钟前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

18分钟前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

18分钟前

山河药辅:股东复星医药拟减持不超过3%公司股份

36氪获悉,山河药辅发布公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。

18分钟前

本页详细列出关于海氏海诺的品牌信息,含品牌所属公司介绍,海氏海诺所处行业的品牌地位及优势。
咨询